• Multiple myeloma
• Chronic Lymphocytic Leukemia
• Waldenström's Macroglobulinemia

Asher A. Chanan-Khan, M.D. is dedicated to advancing and discovering treatments for patients with chronic lymphocytic leukemia (CLL), Waldenstrom macroglobulinemia, and multiple myeloma. He works very closely with both his clinical and research staff to support and improve the quality of life of these patients. For over a decade, Doctor Chanan-Khan has been engaged both in the development of novel therapeutics (the branch of medicine that deals with the treatment and cure of diseases) and extensive laboratory research. His expertise is in preclinical target validation and drug evaluation directed towards early phase clinical trials.